Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Diabenon
- Development stage
- Unknown
- Lead developer
- Ankh Pharmaceuticals
01
Overview
Diabenon is a branded herbal dietary supplement developed by Ankh Pharmaceuticals as part of its Sanjeevini line of Ayurvedic products. It is marketed for general wellness with a specific focus on diabetes support and glycemic management. As an herbal consumer product rather than a regulated pharmaceutical drug candidate, Diabenon does not have a defined molecular target, specific clinical trial phases, or FDA approval for the treatment of medical conditions. It is composed of botanical extracts traditionally used in Ayurvedic medicine for their purported metabolic benefits.
- Brand names
- Diabenon
- Other names
- Diabenon
Beyond the preview
Go deeper on Diabenon.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Diabenon.